TSSNF
Tissue Regenix Group Plc

9
Loading...
Loading...
Tissue Regenix Group Plc is a medical technology company, which develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine. It operates through the following segments: dCELL, BioRinse, GBM-V, and Central. The dCELL segment technology platform removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold. The BioRinse segment offers sterile tissue prepared in a manner to minimise the negative effects of processing. The GBM-V segment is a regional tissue bank based in Rostock, Germany, which currently produces tissue preparations for ophthalmology. The company was founded by Eileen Ingham and John Fisher in May 2006 and is headquartered in Leeds, the United Kingdom.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Tissue Regenix Group Plc?
What is the 52-week high for Tissue Regenix Group Plc?
What is the 52-week low for Tissue Regenix Group Plc?
What is Tissue Regenix Group Plc stock price today?
What was Tissue Regenix Group Plc stock price yesterday?
What is the PE ratio of Tissue Regenix Group Plc?
What is the Price-to-Book ratio of Tissue Regenix Group Plc?
What is the 50-day moving average of Tissue Regenix Group Plc?

Latest TSSNF News

View
No TSSNF news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.